메뉴 건너뛰기




Volumn 70, Issue 8, 2013, Pages 1307-1317

Vascular endothelial growth factor signaling in acute myeloid leukemia

Author keywords

AML; FTL 4; KDR; VEGF; VEGFR 2; VEGFR 3

Indexed keywords

AXITINIB; BEVACIZUMAB; CEDIRANIB; MIDOSTAURIN; SEMAXANIB; SORAFENIB; SUNITINIB; VASCULOTROPIN A; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3; VATALANIB;

EID: 84876682265     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-012-1085-3     Document Type: Review
Times cited : (68)

References (82)
  • 1
    • 79951972587 scopus 로고    scopus 로고
    • Response-guided induction therapy in pediatric acute myeloid leukemia with excellent remission rate
    • 21149663 10.1200/JCO.2010.30.6829
    • Abrahamsson J, Forestier E, Heldrup J et al (2011) Response-guided induction therapy in pediatric acute myeloid leukemia with excellent remission rate. J Clin Oncol 29:310-315
    • (2011) J Clin Oncol , vol.29 , pp. 310-315
    • Abrahamsson, J.1    Forestier, E.2    Heldrup, J.3
  • 2
    • 84864372484 scopus 로고    scopus 로고
    • Clofarabine plus low-dose cytarabine followed by clofarabine plus low-dose cytarabine alternating with decitabine in acute myeloid leukemia frontline therapy for older patients
    • 10.1002
    • Faderl S, Ravandi F, Huang X et al (2012) Clofarabine plus low-dose cytarabine followed by clofarabine plus low-dose cytarabine alternating with decitabine in acute myeloid leukemia frontline therapy for older patients. Cancer. doi: 10.1002
    • (2012) Cancer
    • Faderl, S.1    Ravandi, F.2    Huang, X.3
  • 3
    • 68449101812 scopus 로고    scopus 로고
    • Improved treatment results in Mexican children with acute myeloid leukemia using a Medical Research Council (MRC)-Acute myeloid leukemia 10 modified protocol
    • 19557634 10.1080/10428190902964768 1:CAS:528:DC%2BD1MXnvVOns7c%3D
    • Gallegos-Castorena S, Medina-Sanson A, Gonzalez-Ramella O, Sanchez-Zubieta F, Martinez-Avalos A (2009) Improved treatment results in Mexican children with acute myeloid leukemia using a Medical Research Council (MRC)-Acute myeloid leukemia 10 modified protocol. Leuk Lymphoma 50:1132-1137
    • (2009) Leuk Lymphoma , vol.50 , pp. 1132-1137
    • Gallegos-Castorena, S.1    Medina-Sanson, A.2    Gonzalez-Ramella, O.3    Sanchez-Zubieta, F.4    Martinez-Avalos, A.5
  • 4
    • 77949361873 scopus 로고    scopus 로고
    • Acute leukaemias of ambiguous lineage in children: Characterization, prognosis and therapy recommendations
    • 20085575 10.1111/j.1365-2141.2009.08058.x
    • Gerr H, Zimmermann M, Schrappe M et al (2010) Acute leukaemias of ambiguous lineage in children: characterization, prognosis and therapy recommendations. Br J Haematol 149:84-92
    • (2010) Br J Haematol , vol.149 , pp. 84-92
    • Gerr, H.1    Zimmermann, M.2    Schrappe, M.3
  • 5
    • 3042583628 scopus 로고    scopus 로고
    • MRC trials in childhood acute myeloid leukaemia
    • 15124698
    • Hann IM, Webb DK, Gibson BE, Harrison CJ (2004) MRC trials in childhood acute myeloid leukaemia. Ann Hematol 83(Suppl 1):S108-S112
    • (2004) Ann Hematol , vol.83 , Issue.SUPPL. 1
    • Hann, I.M.1    Webb, D.K.2    Gibson, B.E.3    Harrison, C.J.4
  • 6
    • 65549162784 scopus 로고    scopus 로고
    • Improved patient survival for acute myeloid leukemia: A population-based study of 9729 patients diagnosed in Sweden between 1973 and 2005
    • 19020306 10.1182/blood-2008-09-179341 1:CAS:528:DC%2BD1MXlt1yjs7g%3D
    • Derolf AR, Kristinsson SY, Andersson TM, Landgren O, Dickman PW, Bjorkholm M (2009) Improved patient survival for acute myeloid leukemia: a population-based study of 9729 patients diagnosed in Sweden between 1973 and 2005. Blood 113:3666-3672
    • (2009) Blood , vol.113 , pp. 3666-3672
    • Derolf, A.R.1    Kristinsson, S.Y.2    Andersson, T.M.3    Landgren, O.4    Dickman, P.W.5    Bjorkholm, M.6
  • 7
    • 76049086471 scopus 로고    scopus 로고
    • Independent prognostic factors for AML outcome
    • doi: 10.1182/asheducation-2009.1.385
    • Grimwade D, Hills RK (2009) Independent prognostic factors for AML outcome. Hematology Am Soc Hematol Educ Program. 2009:385-395. doi: 10.1182/asheducation-2009.1.385
    • (2009) Hematology Am Soc Hematol Educ Program. , pp. 385-395
    • Grimwade, D.1    Hills, R.K.2
  • 8
    • 77956587147 scopus 로고    scopus 로고
    • High VEGFC expression is associated with unique gene expression profiles and predicts adverse prognosis in pediatric and adult acute myeloid leukemia
    • 20522712 10.1182/blood-2010-03-270991
    • de Jonge HJ, Valk PJ, Veeger NJ et al (2010) High VEGFC expression is associated with unique gene expression profiles and predicts adverse prognosis in pediatric and adult acute myeloid leukemia. Blood 116:1747-1754
    • (2010) Blood , vol.116 , pp. 1747-1754
    • De Jonge, H.J.1    Valk, P.J.2    Veeger, N.J.3
  • 10
    • 0031039243 scopus 로고    scopus 로고
    • The biology of vascular endothelial growth factor
    • DOI 10.1210/er.18.1.4
    • Ferrara N, Davis-Smyth T (1997) The biology of vascular endothelial growth factor. Endocr Rev 18:4-25 (Pubitemid 27076453)
    • (1997) Endocrine Reviews , vol.18 , Issue.1 , pp. 4-25
    • Ferrara, N.1    Davis-Smyth, T.2
  • 11
    • 12344274486 scopus 로고    scopus 로고
    • The biology of vascular endothelial growth factors
    • DOI 10.1016/j.cardiores.2004.12.002, PII S0008636304005498
    • Tammela T, Enholm B, Alitalo K, Paavonen K (2005) The biology of vascular endothelial growth factors. Cardiovasc Res 65:550-563 (Pubitemid 40138976)
    • (2005) Cardiovascular Research , vol.65 , Issue.3 , pp. 550-563
    • Tammela, T.1    Enholm, B.2    Alitalo, K.3    Paavonen, K.4
  • 14
    • 0036053859 scopus 로고    scopus 로고
    • Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia
    • 12094254 10.1038/sj.leu.2402534 1:CAS:528:DC%2BD38XkvFKrtrs%3D
    • Padro T, Bieker R, Ruiz S et al (2002) Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia. Leukemia 16:1302-1310
    • (2002) Leukemia , vol.16 , pp. 1302-1310
    • Padro, T.1    Bieker, R.2    Ruiz, S.3
  • 16
    • 79953294156 scopus 로고    scopus 로고
    • Repression of vascular endothelial growth factor expression by the runt-related transcription factor 1 in acute myeloid leukemia
    • 21447743 10.1158/0008-5472.CAN-10-0402
    • Ter Elst A, Ma B, Scherpen FJ et al (2011) Repression of vascular endothelial growth factor expression by the runt-related transcription factor 1 in acute myeloid leukemia. Cancer Res 71:2761-2771
    • (2011) Cancer Res , vol.71 , pp. 2761-2771
    • Ter Elst, A.1    Ma, B.2    Scherpen, F.J.3
  • 17
    • 73949133917 scopus 로고    scopus 로고
    • Vascular endothelial growth factor-C (VEGF-C) promotes angiogenesis by induction of COX-2 in leukemic cells via the VEGF-R3/JNK/AP-1 pathway
    • 19825968 10.1093/carcin/bgp244 1:CAS:528:DC%2BD1MXhsFGhurrN
    • Chien MH, Ku CC, Johansson G et al (2009) Vascular endothelial growth factor-C (VEGF-C) promotes angiogenesis by induction of COX-2 in leukemic cells via the VEGF-R3/JNK/AP-1 pathway. Carcinogenesis 30:2005-2013
    • (2009) Carcinogenesis , vol.30 , pp. 2005-2013
    • Chien, M.H.1    Ku, C.C.2    Johansson, G.3
  • 19
    • 40749117992 scopus 로고    scopus 로고
    • Expression of VEGF-C and its receptor VEGFR-3 in the bone marrow of patients with acute myeloid leukaemia
    • DOI 10.1016/j.leukres.2007.10.005, PII S0145212607003992
    • Liersch R, Schliemann C, Bieker R et al (2008) Expression of VEGF-C and its receptor VEGFR-3 in the bone marrow of patients with acute myeloid leukaemia. Leuk Res 32:954-961 (Pubitemid 351389550)
    • (2008) Leukemia Research , vol.32 , Issue.6 , pp. 954-961
    • Liersch, R.1    Schliemann, C.2    Bieker, R.3    Hintelmann, H.4    Buechner, T.5    Berdel, W.E.6    Mesters, R.M.7
  • 20
    • 84876667298 scopus 로고    scopus 로고
    • + pediatric acute myeloid leukemia cells
    • ASH abstract 4319
    • + pediatric acute myeloid leukemia cells. Blood, Suppl ASH abstract 4319
    • (2011) Blood , Issue.SUPPL.
    • Kampen, K.R.1    Ter Elst, A.2    Mulder, A.B.3
  • 21
    • 84876675868 scopus 로고    scopus 로고
    • Targeting multiple active kinase pathways in 11q23 translocated pediatric acute myeloid leukemia using a VEGFR2 antibody together with a MEK inhibitor
    • ASH abstract 3626
    • Ter Elst A, Kampen KR, Diks SH et al (2010) Targeting multiple active kinase pathways in 11q23 translocated pediatric acute myeloid leukemia using a VEGFR2 antibody together with a MEK inhibitor. Blood, Suppl ASH abstract 3626
    • (2010) Blood , Issue.SUPPL.
    • Ter Elst, A.1    Kampen, K.R.2    Diks, S.H.3
  • 22
    • 31144466953 scopus 로고    scopus 로고
    • Phosphorylated KDR can be located in the nucleus of neoplastic cells
    • DOI 10.1038/sj.cr.7310012, PII 7310012
    • Blazquez C, Cook N, Micklem K, Harris AL, Gatter KC, Pezzella F (2006) Phosphorylated KDR can be located in the nucleus of neoplastic cells. Cell Res 16:93-98 (Pubitemid 43129313)
    • (2006) Cell Research , vol.16 , Issue.1 , pp. 93-98
    • Blazquez, C.1    Cook, N.2    Micklem, K.3    Harris, A.L.4    Gatter, K.C.5    Pezzella, F.6
  • 23
    • 2342486598 scopus 로고    scopus 로고
    • Internal and external autocrine VEGF/KDR loops regulate survival of subsets of acute leukemia through distinct signaling pathways
    • DOI 10.1182/blood-2003-05-1634
    • Santos SC, Dias S (2004) Internal and external autocrine VEGF/KDR loops regulate survival of subsets of acute leukemia through distinct signaling pathways. Blood 103:3883-3889 (Pubitemid 38596309)
    • (2004) Blood , vol.103 , Issue.10 , pp. 3883-3889
    • Santos, S.C.R.1    Dias, S.2
  • 24
    • 0037085765 scopus 로고    scopus 로고
    • Vascular endothelial growth factor (VEGF)-C signaling through FLT-4 (VEGFR-3) mediates leukemic cell proliferation, survival, and resistance to chemotherapy
    • DOI 10.1182/blood.V99.6.2179
    • Dias S, Choy M, Alitalo K, Rafii S (2002) Vascular endothelial growth factor (VEGF)-C signaling through FLT-4 (VEGFR-3) mediates leukemic cell proliferation, survival, and resistance to chemotherapy. Blood 99:2179-2184 (Pubitemid 34525504)
    • (2002) Blood , vol.99 , Issue.6 , pp. 2179-2184
    • Dias, S.1    Choy, M.2    Alitalo, K.3    Rafii, S.4
  • 25
    • 0036841072 scopus 로고    scopus 로고
    • Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes
    • DOI 10.1002/cncr.10900
    • Aguayo A, Kantarjian HM, Estey EH et al (2002) Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes. Cancer 95:1923-1930 (Pubitemid 35222172)
    • (2002) Cancer , vol.95 , Issue.9 , pp. 1923-1930
    • Aguayo, A.1    Kantarjian, H.M.2    Estey, E.H.3    Giles, F.J.4    Verstovsek, S.5    Manshouri, T.6    Gidel, C.7    O'Brien, S.8    Keating, M.J.9    Albitar, M.10
  • 26
    • 0036718433 scopus 로고    scopus 로고
    • Vascular endothelial growth factor secretion is an independent prognostic factor for relapse-free survival in pediatric acute myeloid leukemia patients
    • De Bont ES, Fidler V, Meeuwsen T, Scherpen F, Hahlen K, Kamps WA (2002) Vascular endothelial growth factor secretion is an independent prognostic factor for relapse-free survival in pediatric acute myeloid leukemia patients. Clin Cancer Res 8:2856-2861 (Pubitemid 35025730)
    • (2002) Clinical Cancer Research , vol.8 , Issue.9 , pp. 2856-2861
    • De Bont, E.S.J.M.1    Fidler, V.2    Meeuwsen, T.3    Scherpen, F.4    Hahlen, K.5    Kamps, W.A.6
  • 27
    • 60149100926 scopus 로고    scopus 로고
    • The role of VEGF and a functional link between VEGF and p27Kip1 in acute myeloid leukemia
    • 18987662 10.1038/leu.2008.300 1:CAS:528:DC%2BD1MXhs1Olsr0%3D
    • Wegiel B, Ekberg J, Talasila KM, Jalili S, Persson JL (2009) The role of VEGF and a functional link between VEGF and p27Kip1 in acute myeloid leukemia. Leukemia 23:251-261
    • (2009) Leukemia , vol.23 , pp. 251-261
    • Wegiel, B.1    Ekberg, J.2    Talasila, K.M.3    Jalili, S.4    Persson, J.L.5
  • 28
    • 78650138258 scopus 로고    scopus 로고
    • Vascular endothelial growth Factor A isoform mRNA expression in pediatric acute myeloid leukemia
    • 20981743 10.1002/pbc.22783 1:STN:280:DC%2BC3M%2Fjt1Glsw%3D%3D
    • Kruizinga RC, de Jonge HJ, Kampen KR, Walenkamp AM, De Bont ES (2011) Vascular endothelial growth Factor A isoform mRNA expression in pediatric acute myeloid leukemia. Pediatr Blood Cancer 56:294-297
    • (2011) Pediatr Blood Cancer , vol.56 , pp. 294-297
    • Kruizinga, R.C.1    De Jonge, H.J.2    Kampen, K.R.3    Walenkamp, A.M.4    De Bont, E.S.5
  • 29
    • 36849067425 scopus 로고    scopus 로고
    • Vascular endothelial growth factor (VEGF) gene (VEGFA) polymorphism can predict the prognosis in acute myeloid leukaemia patients
    • DOI 10.1111/j.1365-2141.2007.06887.x
    • Kim DH, Lee NY, Lee MH, Sohn SK, Do YR, Park JY (2008) Vascular endothelial growth factor (VEGF) gene (VEGFA) polymorphism can predict the prognosis in acute myeloid leukaemia patients. Br J Haematol 140:71-79 (Pubitemid 350233254)
    • (2008) British Journal of Haematology , vol.140 , Issue.1 , pp. 71-79
    • Kim, D.H.1    Lee, N.Y.2    Lee, M.-H.3    Sohn, S.K.4    Do, Y.R.5    Park, J.Y.6
  • 32
    • 8444239305 scopus 로고    scopus 로고
    • VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small cell lung cancer
    • DOI 10.1016/j.lungcan.2004.04.037, PII S0169500204002053
    • Koukourakis MI, Papazoglou D, Giatromanolaki A, Bougioukas G, Maltezos E, Sivridis E (2004) VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small cell lung cancer. Lung Cancer 46:293-298 (Pubitemid 39487303)
    • (2004) Lung Cancer , vol.46 , Issue.3 , pp. 293-298
    • Koukourakis, M.I.1    Papazoglou, D.2    Giatromanolaki, A.3    Bougioukas, G.4    Maltezos, E.5    Siviridis, E.6
  • 33
    • 0037442985 scopus 로고    scopus 로고
    • Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter
    • Stevens A, Soden J, Brenchley PE, Ralph S, Ray DW (2003) Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter. Cancer Res 63:812-816 (Pubitemid 36231981)
    • (2003) Cancer Research , vol.63 , Issue.4 , pp. 812-816
    • Stevens, A.1    Soden, J.2    Brenchley, P.E.3    Ralph, S.4    Ray, D.W.5
  • 35
    • 82455211264 scopus 로고    scopus 로고
    • Identifying causal rare variants of disease through family-based analysis of Genetics Analysis Workshop 17 data set
    • 10.1186/1753-6561-5-S9-S21 22373204 10.1186/1753-6561-5-S9-S21
    • Yip W, De G, Raby BA et al (2011) Identifying causal rare variants of disease through family-based analysis of Genetics Analysis Workshop 17 data set. BMC Proceedings 5(Suppl 9):S21. doi: 10.1186/1753-6561-5-S9-S21
    • (2011) BMC Proceedings , vol.5 , Issue.SUPPL. 9 , pp. 21
    • Yip, W.1    De, G.2    Raby, B.A.3
  • 36
    • 77953494817 scopus 로고    scopus 로고
    • Genetic association of angiogenesis- and hypoxia-related gene polymorphisms with osteonecrosis of the femoral head
    • 20215856 10.3858/emm.2010.42.5.039 1:CAS:528:DC%2BC3cXnt1Gnsr4%3D
    • Hong JM, Kim TH, Kim HJ, Park EK, Yang EK, Kim SY (2010) Genetic association of angiogenesis- and hypoxia-related gene polymorphisms with osteonecrosis of the femoral head. Exp Mol Med 42:376-385
    • (2010) Exp Mol Med , vol.42 , pp. 376-385
    • Hong, J.M.1    Kim, T.H.2    Kim, H.J.3    Park, E.K.4    Yang, E.K.5    Kim, S.Y.6
  • 37
    • 0035074279 scopus 로고    scopus 로고
    • Effects of vascular endothelial growth factor on acute myelogenous leukemia blasts
    • DOI 10.1089/152581601750098291
    • Foss B, Mentzoni L, Bruserud O (2001) Effects of vascular endothelial growth factor on acute myelogenous leukemia blasts. J Hematother Stem Cell Res 10:81-93 (Pubitemid 32236687)
    • (2001) Journal of Hematotherapy and Stem Cell Research , vol.10 , Issue.1 , pp. 81-93
    • Foss, B.1    Mentzoni, L.2    Bruserud, O.3
  • 38
    • 33645000697 scopus 로고    scopus 로고
    • Enforced expression of KDR receptor promotes proliferation, survival and megakaryocytic differentiation of TF1 progenitor cell line
    • 15962006 10.1038/sj.cdd.4401698 1:CAS:528:DC%2BD2MXht1yktbrP
    • Coppola S, Narciso L, Feccia T et al (2006) Enforced expression of KDR receptor promotes proliferation, survival and megakaryocytic differentiation of TF1 progenitor cell line. Cell Death Differ 13:61-74
    • (2006) Cell Death Differ , vol.13 , pp. 61-74
    • Coppola, S.1    Narciso, L.2    Feccia, T.3
  • 39
    • 0036530301 scopus 로고    scopus 로고
    • 165 promotes survival of leukemic cells by Hsp90-mediated induction of Bcl-2 expression and apoptosis inhibition
    • DOI 10.1182/blood.V99.7.2532
    • Dias S, Shmelkov SV, Lam G, Rafii S (2002) VEGF(165) promotes survival of leukemic cells by Hsp90-mediated induction of Bcl-2 expression and apoptosis inhibition. Blood 99:2532-2540 (Pubitemid 34525442)
    • (2002) Blood , vol.99 , Issue.7 , pp. 2532-2540
    • Dias, S.1    Shmelkov, S.V.2    Lam, G.3    Rafii, S.4
  • 40
    • 53149084152 scopus 로고    scopus 로고
    • Significance of heat-shock protein (HSP) 90 expression in acute myeloid leukemia cells
    • 18386162 10.1007/s12192-008-0035-3 1:CAS:528:DC%2BD1cXhtV2qsbrI
    • Flandrin P, Guyotat D, Duval A et al (2008) Significance of heat-shock protein (HSP) 90 expression in acute myeloid leukemia cells. Cell Stress Chaperones 13:357-364
    • (2008) Cell Stress Chaperones , vol.13 , pp. 357-364
    • Flandrin, P.1    Guyotat, D.2    Duval, A.3
  • 42
    • 33947642080 scopus 로고    scopus 로고
    • Autocrine VEFG loops, signaling pathways, and acute leukemia regulation
    • DOI 10.1080/10428190601064720, PII 773541839
    • Fragoso R, Elias AP, Dias S (2007) Autocrine VEGF loops, signaling pathways, and acute leukemia regulation. Leuk Lymphoma 48:481-488 (Pubitemid 46487754)
    • (2007) Leukemia and Lymphoma , vol.48 , Issue.3 , pp. 481-488
    • Fragoso, R.1    Elias, A.P.2    Dias, S.3
  • 44
    • 70249130158 scopus 로고    scopus 로고
    • Growth inhibition of AML cells with specific chromosome abnormalities by monoclonal antibodies to receptors for vascular endothelial growth factor
    • 19342098 10.1016/j.leukres.2009.03.006 1:CAS:528:DC%2BD1MXhtFKnsbjK
    • Imai N, Miwa H, Shikami M et al (2009) Growth inhibition of AML cells with specific chromosome abnormalities by monoclonal antibodies to receptors for vascular endothelial growth factor. Leuk Res 33:1650-1657
    • (2009) Leuk Res , vol.33 , pp. 1650-1657
    • Imai, N.1    Miwa, H.2    Shikami, M.3
  • 47
    • 77954722597 scopus 로고    scopus 로고
    • Vascular endothelial growth factor receptors VEGFR-2 and VEGFR-3 are localized primarily to the vasculature in human primary solid cancers
    • 20606037 10.1158/1078-0432.CCR-09-2797 1:CAS:528:DC%2BC3cXovVansb4%3D
    • Smith NR, Baker D, James NH et al (2010) Vascular endothelial growth factor receptors VEGFR-2 and VEGFR-3 are localized primarily to the vasculature in human primary solid cancers. Clin Cancer Res 16:3548-3561
    • (2010) Clin Cancer Res , vol.16 , pp. 3548-3561
    • Smith, N.R.1    Baker, D.2    James, N.H.3
  • 48
    • 0032515047 scopus 로고    scopus 로고
    • Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway: Requirement for Flk-1/KDR activation
    • DOI 10.1074/jbc.273.46.30336
    • Gerber HP, McMurtrey A, Kowalski J et al (1998) Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem 273:30336-30343 (Pubitemid 28545503)
    • (1998) Journal of Biological Chemistry , vol.273 , Issue.46 , pp. 30336-30343
    • Gerber, H.-P.1    McMurtrey, A.2    Kowalski, J.3    Yan, M.4    Keyt, B.A.5    Dixit, V.6    Ferrara, N.7
  • 49
    • 33646107369 scopus 로고    scopus 로고
    • VEGF receptor signalling - In control of vascular function
    • 16633338 10.1038/nrm1911 1:CAS:528:DC%2BD28XjslSktrc%3D
    • Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L (2006) VEGF receptor signalling - in control of vascular function. Nat Rev Mol Cell Biol 7:359-371
    • (2006) Nat Rev Mol Cell Biol , vol.7 , pp. 359-371
    • Olsson, A.K.1    Dimberg, A.2    Kreuger, J.3    Claesson-Welsh, L.4
  • 50
    • 0033957420 scopus 로고    scopus 로고
    • Evidence of increased angiogenesis in patients with acute myeloid leukemia
    • Hussong JW, Rodgers GM, Shami PJ (2000) Evidence of increased angiogenesis in patients with acute myeloid leukemia. Blood 95:309-313 (Pubitemid 30017257)
    • (2000) Blood , vol.95 , Issue.1 , pp. 309-313
    • Hussong, J.W.1    Rodgers, G.M.2    Shami, P.J.3
  • 51
    • 0035009960 scopus 로고    scopus 로고
    • Increased bone marrow vascularization in patients with acute myeloid leukaemia: A possible role for vascular endothelial growth factor
    • DOI 10.1046/j.1365-2141.2001.02722.x
    • De Bont ES, Rosati S, Jacobs S, Kamps WA, Vellenga E (2001) Increased bone marrow vascularization in patients with acute myeloid leukaemia: a possible role for vascular endothelial growth factor. Br J Haematol 113:296-304 (Pubitemid 32523131)
    • (2001) British Journal of Haematology , vol.113 , Issue.2 , pp. 296-304
    • De Bont, E.S.J.M.1    Rosati, S.2    Jacobs, S.3    Kamps, W.A.4    Vellenga, E.5
  • 54
    • 84865333261 scopus 로고    scopus 로고
    • High acute myeloid leukemia-derived VEGFA levels are associated with a specific vascular morphology in the leukemic bone marrow
    • 10.1007/s13402-011-0017-9 1:CAS:528:DC%2BC3MXhtFWltbvJ
    • Weidenaar AC, Ter Elst A, Koopmans-Klein G et al (2011) High acute myeloid leukemia-derived VEGFA levels are associated with a specific vascular morphology in the leukemic bone marrow. Cell Oncol (Dordr) 34:289-296
    • (2011) Cell Oncol (Dordr) , vol.34 , pp. 289-296
    • Weidenaar, A.C.1    Ter Elst, A.2    Koopmans-Klein, G.3
  • 55
    • 84876665803 scopus 로고    scopus 로고
    • Patterns of bone marrow micro vessel morphology in AML and high risk MDS predict treatment outcome following intensive chemotherapy and bevacizumab
    • ASH abstract 1555
    • Weidenaar AC, Ter Elst A, van Montfort CAGM et al (2011) Patterns of bone marrow micro vessel morphology in AML and high risk MDS predict treatment outcome following intensive chemotherapy and bevacizumab. Blood, Suppl ASH abstract 1555
    • (2011) Blood , Issue.SUPPL.
    • Weidenaar, A.C.1    Ter Elst, A.2    Van Montfort Cagm3
  • 56
    • 0037114642 scopus 로고    scopus 로고
    • In vivo administration of vascular endothelial growth factor (VEGF) and its antagonist, soluble neuropilin-1, predicts a role of VEGF in the progression of acute myeloid leukemia in vivo
    • DOI 10.1182/blood.V100.13.4622
    • Schuch G, Machluf M, Bartsch G Jr et al (2002) In vivo administration of vascular endothelial growth factor (VEGF) and its antagonist, soluble neuropilin-1, predicts a role of VEGF in the progression of acute myeloid leukemia in vivo. Blood 100:4622-4628 (Pubitemid 35429707)
    • (2002) Blood , vol.100 , Issue.13 , pp. 4622-4628
    • Schuch, G.1    Machluf, M.2    Bartsch Jr., G.3    Nomi, M.4    Richard, H.5    Atala, A.6    Soker, S.7
  • 57
    • 0035499450 scopus 로고    scopus 로고
    • Stem cells find their niche
    • DOI 10.1038/35102160
    • Spradling A, Drummond-Barbosa D, Kai T (2001) Stem cells find their niche. Nature 414:98-104 (Pubitemid 33041633)
    • (2001) Nature , vol.414 , Issue.6859 , pp. 98-104
    • Spradling, A.1    Drummond-Barbosa, D.2    Kai, T.3
  • 58
    • 33644827383 scopus 로고    scopus 로고
    • Bone-marrow haematopoietic-stem-cell niches
    • DOI 10.1038/nri1779, PII N1779
    • Wilson A, Trumpp A (2006) Bone-marrow haematopoietic-stem-cell niches. Nat Rev Immunol 6:93-106 (Pubitemid 43361585)
    • (2006) Nature Reviews Immunology , vol.6 , Issue.2 , pp. 93-106
    • Wilson, A.1    Trumpp, A.2
  • 59
    • 21244463426 scopus 로고    scopus 로고
    • SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells
    • DOI 10.1016/j.cell.2005.05.026, PII S0092867405005404
    • Kiel MJ, Yilmaz OH, Iwashita T, Yilmaz OH, Terhorst C, Morrison SJ (2005) SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121:1109-1121 (Pubitemid 40884400)
    • (2005) Cell , vol.121 , Issue.7 , pp. 1109-1121
    • Kiel, M.J.1    Yilmaz, O.H.2    Iwashita, T.3    Yilmaz, O.H.4    Terhorst, C.5    Morrison, S.J.6
  • 60
    • 58149260269 scopus 로고    scopus 로고
    • Live-Animal tracking of individual haematopoietic stem/progenitor cells in their niche
    • 10.1038/nature07434
    • Lo CC, Fleming HE, Wu JW et al (2009) Live-Animal tracking of individual haematopoietic stem/progenitor cells in their niche. Nature 457:92-96
    • (2009) Nature , vol.457 , pp. 92-96
    • Lo, C.C.1    Fleming, H.E.2    Wu, J.W.3
  • 61
    • 37449021071 scopus 로고    scopus 로고
    • Bone marrow long label-retaining cells reside in the sinusoidal hypoxic niche
    • DOI 10.1016/j.bbrc.2007.11.086, PII S0006291X07024801
    • Kubota Y, Takubo K, Suda T (2008) Bone marrow long label-retaining cells reside in the sinusoidal hypoxic niche. Biochem Biophys Res Commun 366:335-339 (Pubitemid 50016265)
    • (2008) Biochemical and Biophysical Research Communications , vol.366 , Issue.2 , pp. 335-339
    • Kubota, Y.1    Takubo, K.2    Suda, T.3
  • 63
  • 67
    • 42949153257 scopus 로고    scopus 로고
    • Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF
    • DOI 10.1002/path.2319
    • Knowles HJ, Athanasou NA (2008) Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF. J Pathol 215:56-66 (Pubitemid 351619876)
    • (2008) Journal of Pathology , vol.215 , Issue.1 , pp. 56-66
    • Knowles, H.J.1    Athanasou, N.A.2
  • 68
    • 45149117132 scopus 로고    scopus 로고
    • VEGF-C, a lymphatic growth factor, is a RANKL target gene in osteoclasts that enhances osteoclastic bone resorption through an autocrine mechanism
    • 18359770 10.1074/jbc.M708055200 1:CAS:528:DC%2BD1cXltlKjsrk%3D
    • Zhang Q, Guo R, Lu Y et al (2008) VEGF-C, a lymphatic growth factor, is a RANKL target gene in osteoclasts that enhances osteoclastic bone resorption through an autocrine mechanism. J Biol Chem 283:13491-13499
    • (2008) J Biol Chem , vol.283 , pp. 13491-13499
    • Zhang, Q.1    Guo, R.2    Lu, Y.3
  • 69
    • 79551620014 scopus 로고    scopus 로고
    • Inhibition of osteoclast function reduces hematopoietic stem cell numbers in vivo
    • 21131587 10.1182/blood-2010-05-282855 1:CAS:528:DC%2BC3MXit1KksLo%3D
    • Lymperi S, Ersek A, Ferraro F, Dazzi F, Horwood NJ (2011) Inhibition of osteoclast function reduces hematopoietic stem cell numbers in vivo. Blood 117:1540-1549
    • (2011) Blood , vol.117 , pp. 1540-1549
    • Lymperi, S.1    Ersek, A.2    Ferraro, F.3    Dazzi, F.4    Horwood, N.J.5
  • 72
    • 34249721065 scopus 로고    scopus 로고
    • Bevacizumab reduces VEGF expression in patients with relapsed and refractory acute myeloid leukemia without clinical antileukemic activity [6]
    • DOI 10.1038/sj.leu.2404632, PII 2404632
    • Zahiragic L, Schliemann C, Bieker R et al (2007) Bevacizumab reduces VEGF expression in patients with relapsed and refractory acute myeloid leukemia without clinical antileukemic activity. Leukemia 21:1310-1312 (Pubitemid 46831824)
    • (2007) Leukemia , vol.21 , Issue.6 , pp. 1310-1312
    • Zahiragic, L.1    Schliemann, C.2    Bieker, R.3    Thoennissen, N.H.4    Burow, K.5    Kramer, C.6    Zuhlsdorf, M.7    Berdel, W.E.8    Mesters, R.M.9
  • 73
    • 2542547507 scopus 로고    scopus 로고
    • Targeting vascular endothelial growth factor for relapsed and refractory adult acute myelogenous leukemias: Therapy with sequential 1-β -D-Arabinofuranosylcytosine, mitoxantrone, and bevacizumab
    • DOI 10.1158/1078-0432.CCR-03-0627
    • Karp JE, Gojo I, Pili R et al (2004) Targeting vascular endothelial growth factor for relapsed and refractory adult acute myelogenous leukemias: therapy with sequential 1-beta-d-Arabinofuranosylcytosine, mitoxantrone, and bevacizumab. Clin Cancer Res 10:3577-3585 (Pubitemid 38697590)
    • (2004) Clinical Cancer Research , vol.10 , Issue.11 , pp. 3577-3585
    • Karp, J.E.1    Gojo, I.2    Pili, R.3    Gocke, C.D.4    Greer, J.5    Guo, C.6    Qian, D.7    Morris, L.8    Tidwell, M.9    Chen, H.10    Zwiebel, J.11
  • 75
    • 0035412371 scopus 로고    scopus 로고
    • Stable remission after administration of the receptor tyrosine kinase inhibitor SU5416 in a patient with refractory acute myeloid leukemia
    • 11418488 10.1182/blood.V98.1.241 1:CAS:528:DC%2BD3MXkvFSls70%3D
    • Mesters RM, Padro T, Bieker R et al (2001) Stable remission after administration of the receptor tyrosine kinase inhibitor SU5416 in a patient with refractory acute myeloid leukemia. Blood 98:241-243
    • (2001) Blood , vol.98 , pp. 241-243
    • Mesters, R.M.1    Padro, T.2    Bieker, R.3
  • 79
    • 69249221392 scopus 로고    scopus 로고
    • Compassionate use of sorafenib in FLT3-ITD-positive acute myeloid leukemia: Sustained regression before and after allogeneic stem cell transplantation
    • 19389879 10.1182/blood-2009-03-208298 1:CAS:528:DC%2BD1MXotlWru74%3D
    • Metzelder S, Wang Y, Wollmer E et al (2009) Compassionate use of sorafenib in FLT3-ITD-positive acute myeloid leukemia: sustained regression before and after allogeneic stem cell transplantation. Blood 113:6567-6571
    • (2009) Blood , vol.113 , pp. 6567-6571
    • Metzelder, S.1    Wang, Y.2    Wollmer, E.3
  • 80
    • 78049426367 scopus 로고    scopus 로고
    • Phase IIB trial of oral Midostaurin (PKC412), the FMS-like tyrosine kinase 3 receptor (FLT3) and multi-targeted kinase inhibitor, in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome with either wild-type or mutated FLT3
    • 20733134 10.1200/JCO.2010.28.9678 1:CAS:528:DC%2BC3cXhtl2ks7vL
    • Fischer T, Stone RM, Deangelo DJ et al (2010) Phase IIB trial of oral Midostaurin (PKC412), the FMS-like tyrosine kinase 3 receptor (FLT3) and multi-targeted kinase inhibitor, in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome with either wild-type or mutated FLT3. J Clin Oncol 28:4339-4345
    • (2010) J Clin Oncol , vol.28 , pp. 4339-4345
    • Fischer, T.1    Stone, R.M.2    Deangelo, D.J.3
  • 81
    • 84876674315 scopus 로고    scopus 로고
    • Phase II study of AZD2171 for the treatment of patients with acute myelogenous leukemia
    • ASCO, Suppl abstract 6574
    • Juckett M, LaPlant B, Flynn PJ et al (2011) Phase II study of AZD2171 for the treatment of patients with acute myelogenous leukemia. J Clin Oncol 29, ASCO, Suppl abstract 6574
    • (2011) J Clin Oncol , vol.29
    • Juckett, M.1    Laplant, B.2    Flynn, P.J.3
  • 82
    • 71849097154 scopus 로고    scopus 로고
    • Ligand-stimulated VEGFR2 signaling is regulated by co-ordinated trafficking and proteolysis
    • 19883397 10.1111/j.1600-0854.2009.01001.x 1:CAS:528:DC%2BC3cXnsVKg
    • Bruns AF, Herbert SP, Odell AF et al (2010) Ligand-stimulated VEGFR2 signaling is regulated by co-ordinated trafficking and proteolysis. Traffic 11:161-174
    • (2010) Traffic , vol.11 , pp. 161-174
    • Bruns, A.F.1    Herbert, S.P.2    Odell, A.F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.